カテゴリー： MarketsandMarkets, 世界, 医療/バイオ

In situ ハイブリダイゼーション（ISH）の世界市場

【英語タイトル】In situ Hybridization Market by Type (DNA,RNA), Application (Cancer Diagnosis, Cytology, Immunology), End User (Hospitals, Pharma & Biotech, Research Labs) & by Geography - Analysis and Forecast to 2019

MarketsandMarketsが出版した調査資料（MAM-BT-3649）・商品コード：MAM-BT-3649
・発行会社（調査会社）：MarketsandMarkets
・発行日：2015年8月13日
・ページ数：182
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：バイオ技術
◆販売価格オプション（消費税別）
Single UserUSD5,650 ⇒換算￥621,500見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算￥731,500見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算￥896,500見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
当調査レポートでは、In situ ハイブリダイゼーション（ISH）の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観、種類別分析、用途別分析、需要先別分析、地域別分析、市場規模及び予測、競争状況、関連企業分析などの情報をお届けいたします。
【レポートの概要】

In-situ hybridization has applications across varied industry verticals, such as cancer diagnostics, immunology, neurosciences, and cytology. Cancer diagnostics is anticipated to be the leading application segment of the in-situ hybridization market.

The global market is primarily driven by the increasing prevalence of cancer disease, growing usage of personalized medicines for its treatment, rising number of initiatives undertaken by the government, such as create awareness about cancer disease and providing funding to support related researches.

The global in-situ hybridization market is estimated at $554.4 Million 2014 and is projected to reach $681.0 Million by 2019, at a CAGR of 4.2% from 2014 to 2019.

The global in-situ hybridization market has been segmented on the basis of four categories, namely, type, application, end user, and geography. The application segment is subdivided into cancer diagnostics, immunology, neurosciences, cytology, and others. Among applications, the cancer diagnostics segment accounted for the largest share in the global market in 2014, and accounted for a market share of 56.7%. It is estimated to grow at the highest CAGR of 4.7% from 2014 to 2019, due to the increased application of the in-situ hybridization techniques in the diagnosis of cancer.

The market on the basis of geography has been classified into four regions, namely North America, Europe, and Asia-Pacific. North America contributed the largest share to the global market, and the market in the region was valued at $221.8 Million in 2014. It is expected to grow at a CAGR of 4.0% during the given forecast period.

The major players operational in the global in-situ hybridization market are Abbott (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Affymetrix, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), and Agilent Technologies, Inc. (U.S.). These companies have adopted various strategies, such as mergers & acquisitions and partnership, among others to achieve growth in the global market.

[Scope of the Report]
This report categorizes the global market on the basis of type, application, end-user and geography.

• Market Segmentation, by Type:
The in-situ hybridization market has been segmented on the basis of type into DNA in-situ hybridization and RNA in-situ hybridization.

• Market Segmentation, by Application:
The in-situ hybridization market has been segmented on the basis of application into cancer diagnostics, immunology, neurosciences, cytology, and others.

• Market Segmentation, by End-User:
The in-situ hybridization market has been segmented on the basis of end-user into hospitals, pharma & biotech companies, research labs, and CROs.

• Market Segmentation, by Geography:
The geographic analysis covers North America, Europe, and Asia-Pacific.

【レポートの目次】

1 Introduction

2 Executive Summary

3 Market Overview

4 Market Dynamics

5 In-Situ Hybridization Market, By Type

6 In-Situ Hybridization Market, By Application

7 In-Situ Hybridization Market, By End User

8 In-Situ Hybridization Market, By Geography

9 Competitive Landscape

10 Company Profiles
10.1 Abbott
10.2 Biogenex
10.3 Biosb
10.4 F. Hoffmann-La Roche Ltd
10.5 Sigma-Aldrich Co. Llc.
10.6 Advanced Cell Diagnostics
10.7 Affymetrix, Inc.
10.8 Exiqon A/S
10.9 Agilent Technologies
10.10 Thermo Fisher Scientific, Inc.

11 Appendix

List of Tables (40 Tables)

Table 1 In-Situ Hybridization Market, By Type, 2012-2019 (USD MN)
Table 2 DNA In-Situ Hybridization Market, By Geography, 2012-2019 (USD MN)
Table 3 DNA Fluorescent In-Situ Hybridization Market, By Geography, 2012-2019 (USD MN)
Table 4 DNA Chromogenic In-Situ Hybridization Market, By Geography, 2012-2019 (USD MN)
Table 5 RNA In-Situ Hybridization Market, By Geography, 2012-2019 (USD MN)
Table 6 RNA Fluorescent In-Situ Hybridization (FISH) Market, By Geography, 2012-2019 (USD MN)
Table 7 RNA Chromogenic In-Situ Hybridization (CISH) Market, By Geography, 2012-2019 (USD MN)
Table 8 In-Situ Hybridization Market, By Application, 2012-2019 (USD MN)
Table 9 Cancer Diagnostics Market, By Geography, 2012-2019 (USD MN)
Table 10 Cytology Market, By Geography, 2012-2019 (USD MN)
Table 11 Neuroscience Market, By Geography, 2012-2019 (USD MN)
Table 12 Immunology Market, By Geography, 2012-2019 (USD MN)
Table 13 Other Applications Market, By Geography, 2012-2019 (USD MN)
Table 14 Market, By End User, 2012 - 2019 (USD MN)
Table 15 Hospital Market, By Geography, 2012-2019 (USD MN)
Table 16 Pharma & Biotech Companies Market, By Geography, 2012-2019 (USD MN)
Table 17 Research Labs Market, By Geography, 2012-2019 (USD MN)
Table 18 Cros Market, By Geography, 2012-2019 (USD MN)
Table 19 Other End User Market, By Geography, 2012-2019 (USD MN)
Table 20 In-Situ Hybridization Market, By Geography, 2012-2019 (USD MN)
Table 21 North America In-Situ Hybridization Market, By Type, 2012-2019 (USD MN)
Table 22 North America DNA In-Situ Hybridization Market, By Technique, 2012-2019 (USD MN)
Table 23 North America RNA In-Situ Hybridization Market, By Technique, 2012-2019 (USD MN)
Table 24 North America In-Situ Hybridization Market, By Application, 2012-2019 (USD MN)
Table 25 North America In-Situ Hybridization Market, By End User, 2012-2019 (USD MN)
Table 26 Europe In-Situ Hybridization Market, By Type, 2012-2019 (USD MN)
Table 27 Europe DNA In-Situ Hybridization Market, By Technique, 2012-2019 (USD MN)
Table 28 Europe RNA In-Situ Hybridization Market, By Technique, 2012-2019 (USD MN)
Table 29 Europe: Market, By Application, 2012-2019 (USD MN)
Table 30 Europe: Market, By End User, 2012- 2019 (USD MN)
Table 31 APAC: Market, By Type, 2012- 2019 (USD MN)
Table 32 APAC DNA In-Situ Hybridization Market, By Technique, 2012- 2019 (USD MN)
Table 33 APAC RNA In-Situ Hybridization Market, By Technique, 2012-2019 (USD MN)
Table 34 APAC: Market, By Application, 2012-2019 (USD MN)
Table 35 APAC: Market, By End User, 2012-2019 (USD MN)
Table 36 RoW: Market, By Type, 2012- 2019 (USD MN)
Table 37 RoW DNA In-Situ Hybridization Market, By Technique, 2012-2019 (USD MN)
Table 38 RoW RNA In-Situ Hybridization Market, By Technique, 2012-2019 (USD MN)
Table 39 RoW: Market, By Application, 2012-2019 (USD MN)
Table 40 RoW: Market, By End User, 2012- 2019 (USD MN)

List of Figures (35 Figures)

Figures 1 Market Size, 2014 & 2019
Figures 2 Market Size, 2014 & 2019
Figures 3 Market Size, 2014 & 2019
Figures 4 Market Size, 2014 & 2019 (USD MN)
Figures 5 Market, By Type, 2014 & 2019 (USD MN)
Figures 6 DNA In-Situ Hybridization Market, By Technique, 2014 & 2019 (USD MN)
Figures 7 RNA In-Situ Hybridization Market, By Technique, 2014 & 2019 (USD MN)
Figures 8 Market, By Application, 2014 & 2019 (USD MN)
Figures 9 Market, By End-User, 2014 & 2019 (USD MN)
Figures 10 In-Situ Hybridization Market, By Type, 2014 & 2019 (USD MN)
Figures 11 DNA In-Situ Hybridization Market, By Geography, 2012 - 2019 (USD MN)
Figures 12 DNA Fluorescent In-Situ Hybridization Market, By Geography, 2012 - 2019 (USD MN)
Figures 13 DNA Chromogenic In-Situ Hybridization Market, By Geography, 2012 - 2019 (USD MN)
Figures 14 RNA In-Situ Hybridization Market, By Geography, 2012 - 2019 (USD MN)
Figures 15 RNA Fluorescent In-Situ Hybridization (FISH) Market, By Geography, 2012 - 2019 (USD MN)
Figures 16 RNA Chromogenic In-Situ Hybridization (CISH) Market, By Geography, 2012 - 2019 (USD MN)
Figures 17 Market, By Application, 2014 & 2019 (USD MN)
Figures 18 Market, By Application, 2014 & 2019 (USD MN)
Figures 19 Cancer Diagnostics Market, By Geography, 2012 - 2019 (USD MN)
Figures 20 Cytology Market, By Geography, 2012 - 2019 (USD MN)
Figures 21 Neuroscience Market, By Geography, 2012 - 2019 (USD MN)
Figures 22 Immunology Market, By Geography, 2012 - 2019 (USD MN)
Figures 23 Other Application Market, By Geography, 2012 - 2019 (USD MN)
Figures 24 Market, By End User, 2012 - 2019 (USD MN)
Figures 25 End-User Market, By Geography, 2014 & 2019 (USD MN)
Figures 26 Hospitals Market, By Geography, 2012 - 2019 (USD MN)
Figures 27 Pharma & Biotech Companies Market, By Geography, 2012 - 2019 (USD MN)
Figures 28 Research Labs Market, By Geography, 2012 - 2019 (USD MN)
Figures 29 Cros Market, By Geography, 2012 - 2019 (USD MN)
Figures 30 Others Market, By Geography, 2012 - 2019 (USD MN)
Figures 31 In-Situ Hybridization Market, By Geography, 2012 - 2019 (USD MN)
Figures 32 North America: Market, 2014 & 2019 (%)
Figures 33 Europe: Market, 2014 & 2019 (%)
Figures 34 APAC: Market, 2014 & 2019 (%)
Figures 35 RoW: Market, 2014 & 2019 (%)

【レポートのキーワード】

In situ ハイブリダイゼーション（ISH）、DNA、RNA、がん診断、免疫、細胞、in situ ハイブリダイゼーション法用途

★調査レポート[In situ ハイブリダイゼーション（ISH）の世界市場] (コード：MAM-BT-3649)販売に関する免責事項を必ずご確認ください。
★調査レポート[In situ ハイブリダイゼーション（ISH）の世界市場]についてメールでお問い合わせ

※関連調査レポートはありません。


◆H&Iグローバルリサーチのお客様（例）◆